14-day Premium Trial Subscription Sign Up For FreeGet Free

ADMA Biologics Inc Stock Forecast NASDAQ:ADMA

$1.36 (6.25%)

Volume: 2M

Closed: Dec 07, 2021

Hollow Logo Score: -2.167

ADMA Biologics Inc Stock Forecast

$1.36 (6.25%)

Volume: 2M

Closed: Dec 07, 2021

Score Hollow Logo -2.167
Which way will ADMA go? Request
Key Stats
Beta 0.93
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 37 and the stock is currently not being overbought or oversold

A very strong day for ADMA Biologics Inc stock price on Tuesday
(Updated on Dec 07, 2021)

Sell candidate since 2021-12-01 Gain 1.49%

The ADMA Biologics Inc stock price gained 6.25% on the last trading day (Tuesday, 7th Dec 2021), rising from $1.28 to $1.36. During the day the stock fluctuated 7.69% from a day low at $1.30 to a day high of $1.40. The price has fallen in 6 of the last 10 days and is down by -6.21% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 488 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $3.03 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.29 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 23.85% during the next 3 months and, with a 90% probability hold a price between $1.59 and $2.16 at the end of this 3-month period.

Signals & Forecast

There are mixed signals in the stock today. The ADMA Biologics Inc stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term moving average at $1.39. On a fall, the stock will find some support from the short-term average at $1.35. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, November 12, 2021, and so far it has fallen -18.07%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss

ADMA Biologics Inc finds support from accumulated volume at $1.35 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.1000 between high and low, or 7.69%. For the last week, the stock has had a daily average volatility of 6.79%.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is ADMA Biologics Inc stock A Buy?

ADMA Biologics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.167

Predicted Opening Price for ADMA Biologics Inc of Wednesday, December 8, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 8, 2021 Current price
$1.35 $1.36 (Overvalued)
Sell Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 11, 2021 "Raymond James" gave "$5.00" rating for ADMA. The price target was set to $1.60+13.9%.

Volatility and Risk
Daily Average Volatility: 6.79 %
Overall Risk: Very High High Medium Low Very Low
6.79 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $1.41
Price: $1.36
Support: $1.35

ADMA Insider Trading Show all Trades



Last 100 transactions
Buy: 17 502 699 | Sell: 9 136 381 (Shares)
Date Action Amount Person Type
Oct 25, 2021 Buy 250 000 Grossman Adam S Common Stock
Oct 25, 2021 Buy 100 000 Grossman Adam S Common Stock
Oct 25, 2021 Buy 30 000 Lenz Brian Common Stock
Oct 25, 2021 Buy 100 000 Grossman Jerrold B Common Stock
Oct 25, 2021 Buy 100 000 Kwon Young Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 17 502 699 | Sell: 9 136 381 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 1.45 6.86 %
1.42 4.05 %
1.39 2.32 %
Current price: 1.36
Support 1.32 -3.30 %
1.29 -5.03 %
1.25 -7.84 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 1.59 16.91 %
1.55 13.97 %
1.41 3.68 %
Current price 1.36
Support 1.35 -0.74%
1.21 -11.03%
1.18 -13.24%

Click to get the best stock tips daily for free!

About ADMA Biologics Inc

ADMA Biologics ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE